跳至主要内容
临床试验/IRCT201612069014N137
IRCT201612069014N137已完成2 期

Effect of hormonal therapy versus no treatment on testicular histopathology and fertility in patients with non-obstructive azoospermia: a before-after clinical trial

Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences0 个研究点目标入组 28 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Male

入选标准

  • Male; non-obstructive azoospermia; normal sexual hormones.
  • Exclusion criteria: Severe testicular atrophy; varicocele; chromosomal abnormality; sertoli cell syndrome; hypogonadism.

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences

相似试验

招募中
不适用
Comparison between different doses of gonadotropin-releasing hormone agonist used in short stimulation protocol in infertile women undergoing IVFReproductive Health and Childbirth - Fertility including in vitro fertilisationInfertility
ACTRN12613000384752Sarhan IVF Cntre90
进行中(未招募)
不适用
Effect of hormone replacement therapy versus risedronate on fracture recurrence in postmenopausal women with hip fractureEndocrine, nutritional and metabolic disease
KCT0005513Samsung Medical Center300
尚未招募
不适用
The effects of gender affirming hormone therapy on skeletal muscle training and epigeneticsmuscle health and performancebody compositionmetabolic healthgender dysphoriaMusculoskeletal - Normal musculoskeletal and cartilage development and functionMetabolic and Endocrine - Other endocrine disorders
ACTRN12621001415897Victoria University160
已完成
3 期
Comparative effects of 2 types of hormone replacement therapy on climacteric symptomsmenopause.Menopausal and female climacteric states
IRCT138809032766N1Tarbiat Maodares University150
进行中(未招募)
不适用
Modulation of response to hormonal therapy with lapatinib and/or metformin in patients with HER2-negative, ER and/or PgR positive metastatic breast cancer with progressive disease after first-line hormonal therapyFemale patients with HER2-negative, ER and/or PgR positive breast cancer in progression after first-line hormonal therapyMedDRA version: 14.1Level: SOCClassification code 10038604Term: Reproductive system and breast disordersSystem Organ Class: 10038604 - Reproductive system and breast disorders
EUCTR2011-000155-16-ITFONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI